TELA outlines at least 8% 2026 revenue growth while guiding Q2 revenue to about $20.0M
TELA Bio, Inc. Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $0.90
-14% in 3d after detection
Post-detection moves
1h
—
1d
+3.1%
3d
-14%
7d
-7.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS